MGTX
MeiraGTx Holdings plc
NASDAQ · USHealthcareBiotechnology
$12.21-1.85%
Price as of Jul 20, 2026
MGTX profitability
MeiraGTx Holdings plc profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 91.6%
- EBITDA margin
- -120.0%
- EBIT margin
- -131.9%
- Net margin
- -151.1%
- Free cash flow margin
- -2.9%
Returns
- Return on equity
- 207.4%
- Return on assets
- -49.3%
- Return on invested capital
- -357.7%
- Asset turnover
- 0.33x
Cash efficiency
- Cash from operations
- $8.3M
- Cash per share
- $0.77
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.